{ "Study of Show Me FIRST for Anxiety in Phenylketonuria", "This study is looking at a coping skills program called Show Me FIRST for teenagers with Phenylketonuria (PKU). PKU is a genetic condition where the body can't break down a substance called phenylalanine (Phe), which can lead to health problems. The study wants to see if this program can help reduce anxiety and depression in young people aged 10 to 17 who have PKU and have experienced these symptoms. It also aims to test new ways of measuring brain function and psychological well-being \"in the moment.\" To join, you must be 10-17 years old, have a formal diagnosis of PKU, and have received treatment for PKU within the first 30 days of life. The study is currently recruiting 30 participants.", "design": "This is an interventional study with 30 participants, where you would be randomly assigned to either receive the Show Me FIRST program right away or after a waiting period.", "commitments": "You would participate in a 10-week program and complete psychological and brain function evaluations at the start, after 11 weeks, and after 22 weeks. All activities will be done remotely through video calls and phone apps.", "compensation": "Not stated in the trial record.", "follow_up": "You will be followed for 22 weeks after the start of the study, with assessments at weeks 0, 11, and 22.", }

Study design

Not specified.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.